Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Congress 2021: Industry Sponsored Satellite Symposia - Gynaecological Cancers

ESMO Congress 2021 - 1000x250

Friday 17 September

Homologous Recombination Deficiency: BRCA and Beyond

02-Homologous-Recombination-Deficiency-BRCA-and-Beyond-MSD-Thumb

Friday, 08:45 - 09:50
View the satellite invitation

Sunday 19 September

Redefining Long-Term Outcomes in Newly Diagnosed Advanced Ovarian Cancer: Expert Perspectives on Integrating Personalized Medicine

28-Redefining-Long-Term-Outcomes-in-Newly-Diagnosed-Advanced-Ovarian-Cancer-Expert-Perspectives-on-Integrating-Personalized-Medicine-ASTRAZENECA-Thumb

Sunday, 08:45 - 10:15
View the satellite invitation

Biomarkers for Cancer Immunotherapy: The Importance of dMMR/MSI-H for Predicting Response in Solid Tumors

33-Biomarkers-for-Cancer-Immunotherapy-The-Importance-of-dMMR-MSI-H-for-Predicting-Response-in-Solid-Tumors-GSK-Thumb

Sunday, 18:45 - 20:15

View the satellite invitation

Monday 20 September

Developments in Precision Medicine for Breast and Ovarian Cancers

39-Developments-in-Precision-Medicine-for-Breast-and-Ovarian-Cancers-MYRIAD-Thumb

Monday, 08:45 - 10:15
View the satellite invitation

Tuesday 21 September

First-Line PARP Inhibitor Maintenance Therapy in Advanced Ovarian Cancer: Improving Safety Outcomes and the Patient Experience

59-First-Line-PARP-Inhibitor-Maintenance-Therapy-in-Advanced-Ovarian-Cancer-Improving-Safety-Outcomes-and-the-Patient-Experience-GSK-Thumb

Tuesday, 17:35 - 19:05

View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the complete ESMO Congress 2021 Industry Sponsored Satellite Symposia Programme